Drug Class
SGLT2 inhibitor and DPP-4 inhibitor combination
Type
brand
Active Ingredient
empagliflozin and linagliptin
📋Overview
Glyxambi is a prescription medication that combines two active ingredients: empagliflozin and linagliptin. It is primarily used in the management of type 2 diabetes mellitus. The drug works by targeting different pathways to help control blood sugar levels. Glyxambi is associated with conditions related to elevated blood glucose and metabolic disorders.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Glyxambi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.